Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > FEI Unveils Broad Correlative Microscopy Solution Set for Cell Biologists: By combining imaging techniques and efficient workflows, cell biologists could gain a better understanding of the structure and function of cells to improve the treatment of disease

Abstract:
FEI (NASDAQ: FEIC) today announced a suite of solutions for correlative light and electron microscopy (CLEM). New methods in correlative microscopy from FEI bring data from different imaging techniques together automatically in minutes, giving cell biologists the precise information they need, when they need it. Scientists believe that correlating information from the cellular down to the molecular level will lead to breakthrough discoveries that improve their understanding and treatment of diseases, such as cancer, AIDS, and Parkinson's.

FEI Unveils Broad Correlative Microscopy Solution Set for Cell Biologists: By combining imaging techniques and efficient workflows, cell biologists could gain a better understanding of the structure and function of cells to improve the treatment of disease

Hillsboro, OR | Posted on November 26th, 2012

"Light microscopy encompasses a broad and varied set of techniques and methodologies, each with its own requirements for correlation. One workflow does not fit all," said Dominique Hubert, vice president and general manager of FEI's Life Sciences Business Unit. "We have developed a set of workflows that are flexible enough to cover a significant share of the possible applications. And we are committed to extending that coverage as the science develops."

Electron microscopy (EM) offers extremely high image resolution—1,000 or more times better than light microscopes. Light microscopes (LM) offer a wide variety of specialized techniques, such as fluorescent labeling, that can identify a single molecule or structure within a large, complex environment like the interior of a living cell. Correlating between the two techniques allows scientists to use LM to find the target and EM to explore its form and function. Correlative microscopy allows investigators to find a feature of interest faster in the EM, gain additional information about its structure down to the molecular scale, and understand relationships between the feature and its larger scale context.

The correlative microscopy solution set from FEI includes:

· Tecnai™ with iCorr™—a fully-integrated workflow in which the light microscope is incorporated into a transmission electron microscope (TEM) column.

· CorrSight™— an advanced light microscope dedicated to the different steps of correlative experiments, enabling researchers to image live cell dynamics and quickly fix those cells for EM.

· MAPS—a software solution that allows correlation between the electron microscope image and an image from any other source through a simple alignment procedure.

Oregon Health and Science University's Professor Joe Gray, based in Portland, Ore., states, "Biologists want to understand the molecular events and interactions that constitute the larger scale processes we observe in cells and tissues. This will require integration of information from multiple resolution scales, for example, ultrastructural analysis of cells that reside in specific microenvironmental niches. The iCorr system allows us to quickly find fluorescently stained cells of interest using fluorescence microscopy and followed by detailed structural analysis using electron microscopy."

Roger Wepf, director of electron microscopy at the Swiss Federal Institute of Technology in Zurich (ETH Zurich) adds, "With CorrSight, sample preparation for the electron microscope is integrated with the light microscope, using on-board fixation. We identify the target structure and prepare the sample on the CorrSight light microscope platform, then transfer the sample to the electron microscope and, with a few clicks of the mouse, navigate directly the target. This is exactly what we have been missing since it allows us to reduce manual, tedious work and improve reproducibility. CorrSight and MAPS will open new applications in correlative microscopy that were not possible before."

Hubert added, "At this point, we have only glimpsed the potential of correlative microscopy. It promises to open whole new avenues of investigation into the relationships between structure and function in biological systems at the finest scale. FEI is committed to leading the expansion of this applications space by developing correlative workflow solutions for the broadest range of techniques and methodologies."

For more information about the correlative solution set from FEI, please see www.fei.com/correlative-microscopy. For a demonstration of the Tecnai with iCorr, please go to http://fei.com/tecnai_icorr. Or visit FEI at the American Society for Cell Biology Annual Meeting, December 15-19, 2012, San Francisco, Calif., booth 513.

####

About FEI Company
FEI (Nasdaq: FEIC) is a leading diversified scientific instruments company. It is a premier provider of electron- and ion-beam microscopes and solutions for nanoscale applications across many industries: industrial and academic materials research, life sciences, semiconductors, data storage, natural resources and more. With more than 60 years of technological innovation and leadership, FEI has set the performance standard in transmission electron microscopes (TEM), scanning electron microscopes (SEM) and DualBeams™, which combine a SEM with a focused ion beam (FIB). Headquartered in Hillsboro, Ore., USA, FEI has over 2,300 employees and sales and service operations in more than 50 countries around the world. More information can be found at: www.fei.com.

FEI Safe Harbor Statement

This news release contains forward-looking statements that include statements regarding the performance capabilities and benefits of FEI’s correlative solution set: Tecnai with iCorr, CorrSight, and MAPS. Factors that could affect these forward-looking statements include but are not limited to failure of the product or technology to perform as expected and achieve anticipated results, unexpected technology problems and challenges, changes to the technology, the inability of FEI, its suppliers or project partners to make the technological advances required for the technology to achieve anticipated results, the inability of customers to develop and deploy the expected new applications and our ability to manufacture, ship and deliver the tools or software as expected. Please also refer to our Form 10-K, Forms 10-Q, Forms 8-K and other filings with the U.S. Securities and Exchange Commission for additional information on these factors and other factors that could cause actual results to differ materially from the forward-looking statements. FEI assumes no duty to update forward-looking statemen

For more information, please click here

Contacts:
Sandy Fewkes
(media contact)
MindWrite Communications, Inc
+1 408 224 4024


FEI
Fletcher Chamberlin
(investors and analysts)
Investor Relations
+1 503 726 7710

Copyright © FEI Company

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Imaging

New material to make next generation of electronics faster and more efficient With the increase of new technology and artificial intelligence, the demand for efficient and powerful semiconductors continues to grow November 8th, 2024

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Tools

New material to make next generation of electronics faster and more efficient With the increase of new technology and artificial intelligence, the demand for efficient and powerful semiconductors continues to grow November 8th, 2024

Turning up the signal November 8th, 2024

Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024

Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024

Events/Classes

A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024

Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023

CEA & Partners Present ‘Powerful Step Towards Industrialization’ Of Linear Si Quantum Dot Arrays Using FDSOI Material at VLSI Symposium: Invited paper reports 3-step characterization chain and resulting methodologies and metrics that accelerate learning, provide data on device pe June 17th, 2022

June Conference in Grenoble, France, to Explore Pathways to 6G Applications, Including ‘Internet of Senses’, Sustainability, Extended Reality & Digital Twin of Physical World: Organized by CEA-Leti, the Joint EuCNC and 6G Summit Sees Telecom Sector as an ‘Enabler for a Sustainabl June 1st, 2022

Nanobiotechnology

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project